How is ischemic heart disease (IHD) classified?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Classification of Ischemic Heart Disease

Ischemic heart disease is fundamentally classified into two major categories: acute presentations (acute coronary syndromes) and chronic/stable presentations (stable ischemic heart disease), with the most recent 2024 nomenclature proposing the terms "acute myocardial ischemic syndromes" (AMIS) and "non-acute myocardial ischemic syndromes" (NAMIS) to better encompass both obstructive and non-obstructive causes. 1

Primary Classification Framework

Acute Presentations (Acute Coronary Syndromes)

The acute category encompasses conditions caused by unstable plaque rupture with acute thrombosis: 1

  • ST-Elevation Myocardial Infarction (STEMI) - characterized by complete coronary occlusion with ST-segment elevation on ECG and elevated cardiac biomarkers 1, 2

  • Non-ST-Elevation Myocardial Infarction (NSTEMI) - partial coronary occlusion with elevated troponin but without ST-elevation 1, 2

  • Unstable Angina (UA) - myocardial ischemia without detectable myocardial necrosis and normal troponin levels 1, 2

Critical distinction: Unstable angina patients must be further risk-stratified into high, intermediate, and low-risk categories based on clinical features, ECG changes, and cardiac biomarkers. 1

Risk Stratification for Unstable Angina

High-risk features (requiring immediate transfer to emergency department or coronary care unit): 1

  • Prolonged ongoing rest pain (>20 minutes)
  • Pulmonary edema likely due to ischemia
  • New or worsening mitral regurgitation murmur
  • Transient ST-segment changes ≥0.5 mm with rest angina
  • Elevated cardiac troponin (TnT or TnI ≥0.1 ng/mL)
  • Sustained ventricular tachycardia

Intermediate-risk features: 1

  • Prior MI, peripheral or cerebrovascular disease, or CABG
  • Prolonged rest angina (>20 minutes) now resolved
  • Age >70 years
  • T-wave changes or pathological Q waves on ECG
  • Slightly elevated troponin (0.01-0.1 ng/mL)

Low-risk features (addressed in stable IHD guidelines): 1

  • New-onset angina within 2 weeks to 2 months
  • Increased angina frequency, severity, or duration
  • Angina provoked at lower threshold
  • Normal or unchanged ECG
  • Normal cardiac markers

Chronic/Stable Presentations

The chronic category includes: 1

  • Stable Angina - predictable chest discomfort with exertion, relieved by rest or nitroglycerin, reflecting gradual progression of obstructive CAD 1

  • Asymptomatic IHD - patients with known coronary disease who become symptom-free with appropriate therapy 1

  • Ischemic Equivalents - atypical presentations such as dyspnea or arm pain with exertion rather than classic angina 1

Emerging Comprehensive Classification (2024)

The most recent Circulation guidelines propose a paradigm shift to more inclusive terminology: 1

Acute Myocardial Ischemic Syndromes (AMIS)

This encompasses all acute presentations including traditional ACS categories (STEMI, NSTEMI, unstable angina) plus recognition of non-obstructive causes. 1

Non-Acute Myocardial Ischemic Syndromes (NAMIS)

This replaces competing terms like "stable CAD," "stable ischemic heart disease," "chronic coronary syndromes," and "chronic coronary disease" with unified nomenclature. 1

Key advantage of this classification: It explicitly includes both obstructive epicardial coronary disease AND non-obstructive pathogenetic mechanisms including: 1

  • Coronary microvascular dysfunction
  • Vasospastic disorders
  • Non-coronary causes of myocardial ischemia
  • Ischemia and MI with non-obstructive coronary arteries (INOCA/MINOCA)

Myocardial Infarction Type Classification

MI is further subclassified by mechanism: 2, 3

  • Type 1 MI - atherosclerotic plaque rupture, ulceration, fissure, or erosion with intraluminal thrombus 2

  • Type 2 MI - myocardial necrosis from supply-demand mismatch without plaque rupture (e.g., hypotension, severe anemia, tachyarrhythmias, coronary vasospasm) 2, 3

Clinical Presentation-Based Classification

Chest pain characteristics determine initial categorization: 1

  • Typical angina - substernal chest discomfort with radiation to neck/jaw/arms, precipitated by exertion, relieved by rest or nitroglycerin 1

  • Atypical angina - meets only 2 of the 3 typical criteria 1

  • Noncardiac chest pain - meets 1 or none of the typical criteria 1

Important Clinical Pitfalls

Do not assume all IHD is obstructive coronary disease. The restrictive focus on "coronary" and "disease" terminology has historically neglected microvascular dysfunction, vasospasm, and other non-obstructive mechanisms that cause genuine myocardial ischemia and infarction. 1

Low-risk unstable angina overlaps with stable IHD management. These patients can be managed using stable IHD guidelines rather than requiring acute coronary syndrome protocols. 1

Type 2 MI requires different management than Type 1. The absence of acute plaque rupture means the focus shifts to correcting the underlying supply-demand mismatch rather than urgent revascularization. 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Coronary Syndrome and Myocardial Infarction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Demand Ischemia Causes and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.